Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Asia Pacific Wire & Cable Corporation Limited reported a second quarter revenue increase to $136.6 million, an 8% year-over-year rise driven primarily by higher copper prices and strong public sector contract execution. Operating profit increased 36% year-over-year to $3.4 million. However, earnings per share declined sharply by 67% year-over-year …
Rogers Communications has activated its satellite-to-mobile technology for all wireless customers in British Columbia to provide connectivity during the ongoing wildfires. This move enables communication even in areas without traditional cellular coverage, supporting residents and first responders. Additionally, Rogers is supporting wildfire relief…
Cyabra, Inc., an AI-powered platform company that assists governments and enterprises in detecting coordinated manipulation to protect digital trust, announced its upcoming presentation and investor meetings at Sidoti’s Micro-Cap Virtual Investor Conference scheduled for August 19-20, 2026. The event provides Cyabra an opportunity to engage with in…
Reading International, Inc. (NASDAQ: RDI) announced its Q2 2026 results with total revenues rising 11% year-over-year to $66.9 million, marking the strongest second quarter since 2019. Operating income more than doubled to $7.5 million, while EBITDA surged 79% to $11.3 million. The company attributed the strong results primarily to an exceptional m…
YXT.COM GROUP HOLDING Ltd, a NASDAQ-listed technology company focused on AI-native enterprise productivity solutions, announced a registered direct offering of 500,000 American Depositary Shares (ADS) at $3.00 per ADS, raising approximately $1.5 million in gross proceeds. The offering, subject to customary closing conditions, is expected to close a…
SunScout Holding Limited, recently listed on NYSE American and NYSE Texas, signed a Memorandum of Understanding with Alta Renewables to develop, own, and operate a portfolio of four solar-plus-storage projects totaling 87.5 MWp in the Philippines. The projects entail 20-year fixed-price power supply agreements supporting targeted double-digit retur…
DeFi Development Corp., a Nasdaq-listed U.S. company focused on accumulating and compounding Solana (SOL) in its treasury, announced a live event on August 17, 2026, to recap its July progress and review Q2 2026 earnings. The discussion will cover treasury operations, capital markets activity, ecosystem partnerships, and developments in the Solana …
Summary: Michael Page PLC shares jumped 7.4% to 209.4p after UBS upgraded the stock to Buy from Neutral and raised its price target to 235p from 180p. UBS said the specialist recruiter appears to be entering an earnings stabilisation phase seen across the staffing sector, and updated its financial model to reflect stronger margin prospects and a re…
XTEND AI Robotics, soon to trade as XTND on NYSE following its merger with JFB Construction Holdings, is strategically positioned to benefit from new U.S. tariffs of up to 100% on imported drones and components. The company focuses on NDAA-compliant, American-made drone technology with an expanding Tampa-based manufacturing facility, aligning with …
Meta Platforms appears to carry roughly $27 billion of value that is not fully reflected in its balance sheet or share price today. That implicit value — in the form of strategic minority investments, marketable securities and repurchase optionality — creates an asymmetric risk-reward for a long trade. The plan below lays out an entry, stop and tar…
Silexion Therapeutics reported Q2 2026 financials and significant progress on its SIL204 RNAi therapy for KRAS-driven pancreatic cancer, initiating Phase 2/3 clinical trials in Israel and Germany. New preclinical data reveal enhanced immune-sensitization, supporting combination with checkpoint inhibitors. The company also strengthened finances via …
Vivos Therapeutics, Inc., a medical device company specializing in innovative treatments for obstructive sleep apnea (OSA), announced it will release its second quarter 2026 financial results on August 14, 2026, followed by a conference call to discuss operational updates and strategic collaborations aimed at near-term revenue growth and cash burn …
StablecoinX Inc. (Nasdaq: USDE), a publicly traded stablecoin infrastructure company, announced key financial and operational results for Q2 2026, highlighting an ENA treasury of approximately 3.0 billion tokens valued at $218.4 million. The company completed its business combination with TLGY Acquisition Corporation and launched the StablecoinX Ha…
Super Micro (SMCI) posted blowout AI-driven revenue growth and margin improvement but remains discounted after a period of intense scrutiny and dilution fears. With market cap near $25B, EV/Sales under 1x and a crowded short base, the market is pricing a much darker scenario than fundamentals currently imply. This trade targets a recovery once orde…
Hims & Hers (HIMS) faces a regulatory and margin squeeze but has clear levers to recapture gross margin and control growth: bring higher-margin production in-house, integrate Eucalyptus, and monetize diagnostics and telehealth scale. This trade lays out an actionable long with entry at $29.00, a stop loss at $24.00 and a target of $40.00 tied to ma…
NOMAD Power Solutions, formerly LIXTE Biotechnology Holdings, has filed its Q2 2026 Form 10-Q reflecting legacy operations while completing a transformative acquisition of NOMAD Transportable Power Systems. The company rebranded and shifted focus to the AI-driven energy infrastructure sector, enhancing its board and leadership team, advancing its m…
Vistagen Therapeutics provided its Q1 FY 2027 financial results and an update on its clinical programs, highlighting nominally significant improvement in a subgroup of very severe social anxiety patients treated with fasedienol. Despite missing the primary endpoint in the overall Phase 3 PALISADE-4 trial, exploratory analyses suggest potential effi…
BiomX Inc.'s subsidiary Zorronet received a $300,000 purchase order to design, integrate, and deploy a unified operational environment at a defense technology test and evaluation site. This project involves creating a command-and-control center that integrates communications, computing, and control systems to improve coordination, safety, and opera…
AIB Data Centers Inc. reported Q2 2026 results highlighting a strengthened balance sheet with $52.8 million cash, a new 65 MW 15-year power contract at CLT-01 data center, and identified 570 MW of potential AI/HPC capacity. The company raised $59 million in a public offering, completed a rebrand, and is transitioning towards long-term AI and HPC in…
Microsoft sits at the center of the enterprise AI boom: massive cloud scale, sticky SaaS cash flow, and a fortress balance sheet. At $496.84 the stock looks like a high-quality, mid-priced entry into AI exposure — not the cheapest, but one of the safest ways to play large-scale generative AI adoption. This trade plan lays out an entry, stop, and ta…
Quoin Pharmaceuticals Ltd., a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, reported significant progress in Q2 2026 including FDA conditional approval of QYLEKI™ (QRX003) brand name, positive clinical updates from pediatric compassionate use program in Netherton Syndrome, receipt of a U.S. patent allowan…
Duos Technologies Group, a Nasdaq-listed provider of edge data center solutions, announced that its Q2 2026 earnings press release will be issued on August 17, 2026. The company will hold a conference call the same day to discuss business updates and outlook.
Moleculin Biotech announced positive interim results from its pivotal Phase 2/3 MIRACLE trial of Annamycin in relapsed or refractory acute myeloid leukemia (AML), showing complete remission rates three times higher than the control arm. Enrollment is progressing towards the 90-patient milestone, with data readout expected between December 2026 and …
Zeo Energy Corp., a US-based residential solar and commercial energy storage provider, reported a mixed Q2 2026 earnings season. Despite a 10.7% revenue decline in Q2 compared to last year and pressure on gross margins, H1 2026 revenue grew 9.2%. The company achieved improved contribution profit and significantly reduced net loss compared to prior …
Clene Inc. reported its second quarter 2026 financial results and announced its plan to submit a New Drug Application (NDA) for CNM-Au8 under the FDA's accelerated approval pathway for amyotrophic lateral sclerosis (ALS). New biomarker analyses from phase 2 trials show CNM-Au8-treated patients with stabilized or reduced neurofilament light (NfL) le…
